| |
| |
|
| Insider
Information: |
Robb Gary Charles |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
20,203 |
|
|
Indirect Shares
|
25,100 |
|
|
| Direct
Value |
$460,628 |
|
|
|
Indirect Value
|
$572,280 |
|
|
| Total
Shares |
45,303 |
|
|
| Total
Value |
$1,032,908 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
10
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
| Percentage
Gain/Loss : |
0.0%
|
 -32.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
|
2024-03-01 |
20,203 |
2024-03-01 |
25,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$16,770 |
D/D |
1,394 |
20,203 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2024-03-01 |
4 |
D |
$24.06 |
$15,783 |
D/D |
(656) |
18,809 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
750 |
20,640 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,000) |
7,700 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,917 |
8,700 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-06 |
4 |
S |
$27.01 |
$167,786 |
D/D |
(6,212) |
21,390 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-05 |
4 |
S |
$26.27 |
$36,277 |
D/D |
(1,381) |
27,602 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-04 |
4 |
OE |
$3.29 |
$49,350 |
D/D |
15,000 |
37,771 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-04 |
4 |
D |
$26.26 |
$230,773 |
D/D |
(8,788) |
28,983 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-01 |
4 |
A |
$0.00 |
$16,569 |
D/D |
1,276 |
22,771 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-19 |
4 |
S |
$32.74 |
$163,677 |
D/D |
(5,000) |
21,996 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-14 |
4 |
D |
$33.80 |
$270,265 |
D/D |
(7,996) |
26,996 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-14 |
4 |
OE |
$3.29 |
$45,938 |
D/D |
13,963 |
34,992 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-01 |
4 |
A |
$0.00 |
$16,550 |
D/D |
1,000 |
21,029 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-06-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
20,029 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-06-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,175 |
8,061 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-06-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,550 |
20,629 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-06-01 |
4 |
A |
$0.00 |
$48,030 |
D/D |
4,182 |
24,179 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-05-10 |
4 |
S |
$24.07 |
$336,980 |
D/D |
(14,000) |
19,997 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-05-09 |
4 |
S |
$23.87 |
$716,100 |
D/D |
(30,000) |
33,997 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-05-05 |
4 |
D |
$24.07 |
$1,458,305 |
D/D |
(60,586) |
63,997 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-05-05 |
4 |
OE |
$1.92 |
$283,800 |
D/D |
105,000 |
124,583 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$31,776 |
D/D |
3,200 |
19,583 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-11-23 |
4 |
S |
$26.03 |
$4,842 |
D/D |
(186) |
21,143 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-11-22 |
4 |
S |
$26.03 |
$125,308 |
D/D |
(4,814) |
21,329 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
